O. Yeku, A. Russo, A. Bregar, J. Brower, A. Dinesh, S. Bouberhan, P. Widick, J. Jang, T. Colella, J. Filipi, E.L. Eisenhauer, C.S. Kournioti, A. Goodman, D. Spriggs, H. Lee, C.M. Castro
{"title":"102P Interim safety analysis of a phase II trial of cisplatin-sensitized radiation therapy and pembrolizumab for unresectable vulvar cancer","authors":"O. Yeku, A. Russo, A. Bregar, J. Brower, A. Dinesh, S. Bouberhan, P. Widick, J. Jang, T. Colella, J. Filipi, E.L. Eisenhauer, C.S. Kournioti, A. Goodman, D. Spriggs, H. Lee, C.M. Castro","doi":"10.1016/j.iotech.2023.100574","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100574","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":" 25","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138620215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
N.J. Venturini, P. Hamon, S. Ward, M.I. Fiel, M.B. Beasley, E. Kim, K. Garcia-Reyes, U. Chaddha, T. Harkin, G. Gunasekaran, P. Tabrizian, D. Nicastri, D. Del Valle, C. Hennequin, S. Kim-Schulze, S. Gnjatic, M. Schwartz, A. Kaufman, M. Merad, T.U. Marron
{"title":"170P Targeting myeloid cells in non-small cell lung cancer and hepatocellular carcinoma: A window-of-opportunity trial of nivolumab with BMS-813160 (CCR2/5i) or BMS-986253 (anti-IL8)","authors":"N.J. Venturini, P. Hamon, S. Ward, M.I. Fiel, M.B. Beasley, E. Kim, K. Garcia-Reyes, U. Chaddha, T. Harkin, G. Gunasekaran, P. Tabrizian, D. Nicastri, D. Del Valle, C. Hennequin, S. Kim-Schulze, S. Gnjatic, M. Schwartz, A. Kaufman, M. Merad, T.U. Marron","doi":"10.1016/j.iotech.2023.100629","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100629","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":"14 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138621249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
B. Kushner, J. Mora, G. Chan, D.A. Morgenstern, L. Amoroso, K. Nysom, J. Faber, A. Wingerter, M. Bear, A. R. San Simón, M. During, K. Tornøe
{"title":"129P Naxitamab efficacy in patients with refractory/relapsed high-risk neuroblastoma and bone metastases as assessed by Curie score","authors":"B. Kushner, J. Mora, G. Chan, D.A. Morgenstern, L. Amoroso, K. Nysom, J. Faber, A. Wingerter, M. Bear, A. R. San Simón, M. During, K. Tornøe","doi":"10.1016/j.iotech.2023.100601","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100601","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":"74 1‐2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138622092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
R. Leibowitz-Amit, S. Feldman, B. Daana, L. Elkis, S. Mendelovic, A. Avraham
{"title":"188P Expression of the co-stimulatory checkpoint protein OX40L (TNFSF4) in the melanoma micro-environment","authors":"R. Leibowitz-Amit, S. Feldman, B. Daana, L. Elkis, S. Mendelovic, A. Avraham","doi":"10.1016/j.iotech.2023.100647","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100647","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":"10 42","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138623969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Valente, M. Colucci, V. Vegni, V. Croce, C. Bellan, G. Rossi, G. Gibilisco, F. Frongia, R. Guazzo, C. Ghiribelli, V. Savelli, M. Ravara, T. Sani, E. Simonetti, M. Maio, L. Calabro, A. M. Di Giacomo
{"title":"113P A multidisciplinary management of immune-checkpoint inhibitor (ICI)-related pneumonitis to improve its clinical management","authors":"M. Valente, M. Colucci, V. Vegni, V. Croce, C. Bellan, G. Rossi, G. Gibilisco, F. Frongia, R. Guazzo, C. Ghiribelli, V. Savelli, M. Ravara, T. Sani, E. Simonetti, M. Maio, L. Calabro, A. M. Di Giacomo","doi":"10.1016/j.iotech.2023.100585","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100585","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":"32 29","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138624785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
G. G. Dorbes, N. Loukili, A. Petain, J. Labbe, N. Boute, B. Akla, M. Broussas, P. Ferré, F. Hofmann
{"title":"147P Pre-clinical evaluation and safety profile of the highly selective anti-VISTA antibody K01401-020","authors":"G. G. Dorbes, N. Loukili, A. Petain, J. Labbe, N. Boute, B. Akla, M. Broussas, P. Ferré, F. Hofmann","doi":"10.1016/j.iotech.2023.100619","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100619","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":"103 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138608976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
I. Winer, R. E. O'Cearbhaill, S. Bouberhan, J.L. Hays, R.M. Wenham, D.R. Roque, O. Yeku, J.F. Liu, B. Wang, Suk-Young Yoo, S. Govindraj, M. Zhu, J. Brouwer-Visser, M. Peterman, B. Barnes, I. Lowy, D. Knorr, T.S. Uldrick, E.A. Miller
{"title":"127P REGN5668 (MUC16xCD28 bispecific antibody) with cemiplimab (anti-PD-1 antibody) in recurrent ovarian cancer: Phase I dose-escalation study","authors":"I. Winer, R. E. O'Cearbhaill, S. Bouberhan, J.L. Hays, R.M. Wenham, D.R. Roque, O. Yeku, J.F. Liu, B. Wang, Suk-Young Yoo, S. Govindraj, M. Zhu, J. Brouwer-Visser, M. Peterman, B. Barnes, I. Lowy, D. Knorr, T.S. Uldrick, E.A. Miller","doi":"10.1016/j.iotech.2023.100599","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100599","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":" 34","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138612636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
E.M. Inderberg, S.J. Arbe-Barnes, J.A. Eriksen, B. Iverson, H. K. Eriksen, R.M. Miller, K. R. Handeland, H. V. Juul, N. Singh
{"title":"138P Generation of frameshift mutated TGFβR2-specific T cells in healthy subjects following administration with cancer vaccine candidate FMPV-1/GM-CSF","authors":"E.M. Inderberg, S.J. Arbe-Barnes, J.A. Eriksen, B. Iverson, H. K. Eriksen, R.M. Miller, K. R. Handeland, H. V. Juul, N. Singh","doi":"10.1016/j.iotech.2023.100610","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100610","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":"124 26","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138608251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Możejko, K. Gogolewski, D. Schulz, N. Eling, J. Krawczyk, A. Możwiłło, M. Daniel, E. Staub, M. Mourface, H.S. Hong, B. Bodenmiller, E. Szczurek
{"title":"202P Discovery of immunological cellular neighborhoods from protein markers in spatial tumor data","authors":"M. Możejko, K. Gogolewski, D. Schulz, N. Eling, J. Krawczyk, A. Możwiłło, M. Daniel, E. Staub, M. Mourface, H.S. Hong, B. Bodenmiller, E. Szczurek","doi":"10.1016/j.iotech.2023.100678","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100678","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":" 40","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138613813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
T. Medina, J. Chesney, E. Whitman, H. Kluger, S. Thomas, A. Sarnaik, J. M. Kirkwood, J. Larkin, J. Weber, O. Hamid, M. Wermke, F. Finckenstein, J. Chou, B. Gastman, G. Sulur, X. Wu, W. Shi, E. Domingo-Musibay
{"title":"119O Long-term efficacy and patterns of response of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced melanoma: A 4-year analysis of the C-144-01 study","authors":"T. Medina, J. Chesney, E. Whitman, H. Kluger, S. Thomas, A. Sarnaik, J. M. Kirkwood, J. Larkin, J. Weber, O. Hamid, M. Wermke, F. Finckenstein, J. Chou, B. Gastman, G. Sulur, X. Wu, W. Shi, E. Domingo-Musibay","doi":"10.1016/j.iotech.2023.100591","DOIUrl":"https://doi.org/10.1016/j.iotech.2023.100591","url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":" 34","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138615743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
